Clearing the Path for Generic Drug Utilization

Lessons from Worldwide Investigations

Autori

  • Andrei Dumitrescu Departamentul de Sănătate și Medicină Tradițională, Universitatea București Nova, Bucharest, Romania
  • Cristian Iliescu Departamentul de Sănătate și Medicină Tradițională, Universitatea București Nova, Bucharest, Romania
  • Bogdan Mihai Departamentul de Sănătate și Medicină Tradițională, Universitatea București Nova, Bucharest, Romania

Cuvinte cheie:

Generic medications, Proprietary pharmaceuticals, Severe healthcare costs, Consciousness, Impediments to Integration

Rezumat

This review aims to provide concise insights into global consumer awareness of generic drugs, challenges identified in diverse studies regarding their adoption, and proposed solutions to enhance availability, accessibility, and affordability. Despite the economic benefits of generic drugs, patient reluctance persists. Aligned with the UN's Sustainable Development Goals, this exploration delves into historical perspectives, patenting challenges, and the impact on healthcare costs. Drawing from various online sources, research articles, and reviews, the study concludes that, although generic drugs are equally effective and cost-effective, barriers to adoption stem from consumer perceptions influenced by factors like age, education, health literacy, income, and trust in prescribers. Additionally, country-specific policies and regulatory frameworks play a crucial role in shaping adoption rates, suggesting a need for targeted educational interventions to address these challenges and promote wider acceptance of generic medications.

##plugins.generic.usageStats.downloads##

##plugins.generic.usageStats.noStats##

Referințe

Alongi, Al-Gedadi, N. A., Hassali, M. A., & Shafie, A. A. (2008). A pilot survey on perceptions and knowledge of generic medicines among consumers in Penang, Malaysia. Pharmacy Practice, 6(2), 93–97. https://doi.org/10.4321/s1886-36552008000200006

Kapczynski, A. (2009). Harmonization and its discontents: A case study of TRIPS implementation in India’s pharmaceutical sector. California Law Review, 97, 1571.

IvyPanda. (2019, November 22). ‘The Indian Challenge: The Evolution of a Successful New Global Strategy in the Pharmaceutical Industry’ by D. Jane Bower and Julian C. Sulez.

Tripathi, S., & Bhattacharya, S. (2018). Patient perception about generic vs. branded medicines prescribed in a tertiary care hospital in northern India -A descriptive study. Indian Journal of Pharmacy Practice, 11(2), 91–95. https://doi.org/10.5530/ijopp.11.2.19

Wyszewianski, L. (1986). Financially catastrophic and high-cost cases: Definitions, distinctions, and their implications for policy formulation. Inquiry, 23(4), 382–394. PubMed: 2947859

Bertoldi, A. D., Barros, A. J. D., & Hallal, P. C. (2005). Generic drugs in Brazil: Known by many, used by few. Cadernos de Saúde Pública, 21(6), 1808–1815. https://doi.org/10.1590/s0102-311x2005000600029

Descărcări

Publicat

2023-06-08

Cum cităm

Dumitrescu, A., Iliescu, C., & Mihai, B. (2023). Clearing the Path for Generic Drug Utilization: Lessons from Worldwide Investigations. Inventum Biologicum: An International Journal of Biological Research, 3(2), 58–61. Preluat în din https://journals.worldbiologica.com/ib/article/view/59

Număr

Vol. 3 Nr. 2 (2023)

Secțiune

Review article

Licență

Copyright (c) 2023 Inventum Biologicum: An International Journal of Biological Research

Creative Commons License

TAceastă lucrare este licențiată în temeiul Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.